These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


172 related items for PubMed ID: 7836509

  • 1. Follicle stimulating hormone (FSH) dynamics of low dose step-up ovulation induction with FSH in patients with polycystic ovary syndrome.
    van der Meer M, Hompes PG, Scheele F, Schoute E, Veersema S, Schoemaker J.
    Hum Reprod; 1994 Sep; 9(9):1612-7. PubMed ID: 7836509
    [Abstract] [Full Text] [Related]

  • 2. Pharmaco-dynamics of human menopausal gonadotrophin (HMG) and follicle-stimulating hormone (FSH). The importance of the FSH concentration in initiating follicular growth in polycystic ovary-like disease.
    van Weissenbruch MM, Schoemaker HC, Drexhage HA, Schoemaker J.
    Hum Reprod; 1993 Jun; 8(6):813-21. PubMed ID: 8345068
    [Abstract] [Full Text] [Related]

  • 3. Ovulation induction with low doses of "pure" follicle stimulating hormone using a fixed protocol in patients with polycystic ovarian disease.
    Bregieiro LO, de Moura MD, Ferriani RA, Bailão LA, de Sá MF.
    Int J Fertil Menopausal Stud; 1993 Jun; 38(3):152-9. PubMed ID: 8348163
    [Abstract] [Full Text] [Related]

  • 4. Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens.
    Balasch J, Fábregues F, Creus M, Puerto B, Peñarrubia J, Vanrell JA.
    Hum Reprod; 2001 Apr; 16(4):652-6. PubMed ID: 11278212
    [Abstract] [Full Text] [Related]

  • 5. The step-down principle in gonadotrophin treatment and the role of GnRH analogues.
    Fauser BC, Donderwinkel P, Schoot DC.
    Baillieres Clin Obstet Gynaecol; 1993 Jun; 7(2):309-30. PubMed ID: 8358893
    [Abstract] [Full Text] [Related]

  • 6. Sequential step-up and step-down dose regimen: an alternative method for ovulation induction with follicle-stimulating hormone in polycystic ovarian syndrome.
    Hugues JN, Cédrin-Durnerin I, Avril C, Bulwa S, Hervé F, Uzan M.
    Hum Reprod; 1996 Dec; 11(12):2581-4. PubMed ID: 9021354
    [Abstract] [Full Text] [Related]

  • 7. The importance of endogenous feedback for monofollicular growth in low-dose step-up ovulation induction with follicle-stimulating hormone in polycystic ovary syndrome: a randomized study.
    van der Meer M, Hompes PG, Scheele F, Schoute E, Popp-Snijders C, Schoemaker J.
    Fertil Steril; 1996 Oct; 66(4):571-6. PubMed ID: 8816618
    [Abstract] [Full Text] [Related]

  • 8. Ovulation induction with low-dose follicle-stimulating hormone in women with the polycystic ovary syndrome.
    Dale O, Tanbo T, Lunde O, Abyholm T.
    Acta Obstet Gynecol Scand; 1993 Jan; 72(1):43-6. PubMed ID: 8382432
    [Abstract] [Full Text] [Related]

  • 9. Early prediction of ovarian multifollicular response during ovulation induction in patients with polycystic ovary syndrome.
    Farhi J, Jacobs HS.
    Fertil Steril; 1997 Mar; 67(3):459-62. PubMed ID: 9091330
    [Abstract] [Full Text] [Related]

  • 10. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
    Köninger A, Sauter L, Edimiris P, Kasimir-Bauer S, Kimmig R, Strowitzki T, Schmidt B.
    Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of low dose purified FSH in ovulation induction following pituitary desensitization in polycystic ovarian syndrome.
    Buckler HM, Critchley HO, Cantrill JA, Shalet SM, Anderson DC, Robertson WR.
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):209-17. PubMed ID: 8435902
    [Abstract] [Full Text] [Related]

  • 12. Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome.
    Polson DW, Mason HD, Saldahna MB, Franks S.
    Clin Endocrinol (Oxf); 1987 Feb; 26(2):205-12. PubMed ID: 3117445
    [Abstract] [Full Text] [Related]

  • 13. The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome.
    Dale PO, Tanbo T, Haug E, Abyholm T.
    Hum Reprod; 1998 Mar; 13(3):567-70. PubMed ID: 9572412
    [Abstract] [Full Text] [Related]

  • 14. Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome.
    Schoot DC, Hop WC, de Jong FH, van Dessel TJ, Fauser BC.
    Fertil Steril; 1995 Dec; 64(6):1081-7. PubMed ID: 7589656
    [Abstract] [Full Text] [Related]

  • 15. Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development.
    Hohmann FP, Laven JS, de Jong FH, Eijkemans MJ, Fauser BC.
    Hum Reprod; 2001 May; 16(5):846-54. PubMed ID: 11331627
    [Abstract] [Full Text] [Related]

  • 16. Comparison of two different starting doses of recombinant follicle stimulating hormone (rFSH) for intrauterine insemination (IUI) cycles in non-obese women with polycystic ovary syndrome (PCOS): a retrospective cohort study.
    Seckin B, Yumusak OH, Tokmak A.
    J Obstet Gynaecol; 2021 Nov; 41(8):1234-1239. PubMed ID: 33624571
    [Abstract] [Full Text] [Related]

  • 17. Polycystic ovary syndrome: low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients.
    Dale PO, Tanbo T, Haug E, Abyholm T.
    Hum Reprod; 1992 Sep; 7(8):1085-9. PubMed ID: 1400931
    [Abstract] [Full Text] [Related]

  • 18. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J, Ruiz Balda JA, Romeu Sarrió A, Caballero Fernández V, Cano Trigo I, Gómez Parga JL, González Batres C, Rodríguez Escudero FJ.
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [Abstract] [Full Text] [Related]

  • 19. Responses of polycystic ovarian syndrome and related variants to low-dose follicle stimulating hormone.
    Yong EL, Ng SC, Chan C, Kumar J, Teo LS, Ratnam S.
    Int J Gynaecol Obstet; 1997 Jun; 57(3):305-11. PubMed ID: 9215494
    [Abstract] [Full Text] [Related]

  • 20. Low-dose follicle stimulating hormone for ovulation induction in polycystic ovary syndrome.
    Strowitzki T, Seehaus D, Korell M, Hepp H.
    J Reprod Med; 1994 Jul; 39(7):499-503. PubMed ID: 7966037
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.